Grand Rounds in Urology Contributing Editor Neil H. Baum, MD, engages with Paul Perito, MD, FACS, a leading expert in urology. Considered by urologists as the Prince of Prosthetics, Dr. Perito is the leading penile implanter in the world. He has trained hundreds of urologists in his minimally invasive technique, which has streamlined the procedure and reduced implantation time to less than 20 minutes.
Read More
Grand Rounds in Urology Contributing Editor Neil H. Baum, MD, interviews Alan Wein, MD, PhD, FACS, on the past, present, and future of overactive bladder treatment in Urology. Among his many achievements, Dr. Wein has co-written or co-edited +30 books on Urology, including several editions of the textbook, Campbell Walsh Wein Urology, and holds editorial board positions on 14 journals. Additionally, Dr. Wein is largely credited as the researcher who lead the charge to rename “unstable bladder” to overactive bladder.
In this interview, they discuss Dr. Wein’s perspective on:
The History of Overactive Bladder
The Role of Pharmacology in Lower Urinary Tract Dysfunction
The Evolution of Incontinence and Overactive Bladder Treatments
The Role of AI and Telemedicine in Treatment
The Future of Urinary Incontinence and Overactive Bladder Management
Grand Rounds in Urology Contributing Editor Neil H. Baum, MD, interviews revolutionary urogynecologist, Mickey Karram, MD, on topics ranging from urogynecological cosmetic surgeries to robotic pelvic reconstruction. Dr. Karram is an internationally renowned urogynecologist and pelvic surgeon, widely considered to be a pioneer in the field. He has co-authored several of the leading textbooks and reference books in the study of Urogynecology, in addition to publishing over 200 peer-reviewed articles in medical journals.
In this interview, Dr. Karram shares his insights on:
Fostering Collaboration Between Urology and Gynecology Specialists
Urogynecological Cosmetic Procedures
Female Sexual Dysfunction
The Use of Robotics in Pelvic Reconstruction
The Future of Pelvic Reconstruction
Grand Rounds in Urology contributing editor Neil H. Baum, MD, interviews Sue and Irwin Goldstein, MD, on their influential roles in the field of sexual medicine. Dr. Goldstein has authored over 360 publications and his contributions have significantly shaped the study of sexual health, while Sue has played a vital role in pioneering research on female sexual dysfunction, culminating in the establishment of the International Society for the Study of Women’s Sexual Health (ISSWSH) in 2000.
They discuss the groundbreaking impact of Viagra, as well as the evolution of women’s sexual health as a recognized discipline. Sue highlights the prevalence of female sexual dysfunction, shedding light on issues like sexual desire problems and the underreported concern of pain, affecting 43% of women. Dr. Goldstein addresses challenges faced in sexual medicine, citing issues related to knowledge, information, and finances. The Goldsteins’ unique approach involves extensive patient interaction, including in-depth interviews and testing, underlining the necessity of time to advance the field.
The two also detail the ‘orgasm gap,’ with Sue discussing the International Society for the Study of Women’s Sexual Health’s ongoing work to understand and address orgasm-related issues, and Dr. Goldstein sharing insights into physiological pathways related to pain and orgasm.
Sue details common conditions urologists can address in women, such as genitourinary syndrome of menopause (GSM), hypoactive sexual desire disorder (HSDD), and pain, emphasizing the crucial role urologists can play in menopause management.
Both Goldsteins advocate for urologists’ involvement in women’s sexual health, recommending participation in the ISSWSH events. They express commitment to training residents and fellows, encouraging interested individuals to reach out for opportunities.
Read More
In his latest interview with iconic physicians in urology, uro-oncology, and related fields, Grand Rounds in Urology (GRU) contributing editor Neil H. Baum, MD, interviews Bela Denes, MD, Vice President of Global Medical Affairs at Lantheus Medical Imaging, focusing on his remarkable career in the pharmaceutical and medical device industries after his time as a practicing clinician. Dr. Denes reflects that his transition from clinical practice to industry giants like Amgen, Eli Lilly, and Pfizer, was driven by various factors, including the recognition of burnout among colleagues in clinical practice and a desire for new opportunities.
Dr. Denes discusses the evolving landscape of drug development and the increasing need for urology expertise in the pharmaceutical industry. He emphasizes the importance of clinical experience in understanding diseases, patient management, and designing effective studies.
Dr. Denes also shares insights into the challenges and rewards of working in the industry, including the long-term impact of industry contributions and the benefits of learning about regulatory pathways and drug approval processes. Dr. Denes highlights the differences between device regulatory pathways and drug development. He discusses the potential advantages of single-use cystoscopes, such as cost-efficiency, convenience, and reduced environmental impact. He predicts that economics and environmental considerations will play a significant role in the adoption of single-use instruments in urology.
Read More